Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MenABCWY Vaccine Formulations in Adolescents
NCT01210885Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2010
- Primary completion
- Jul 2011
- Modality
- Split/Subunit Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of Meningococcal ABCWY in meningococcal meningitis, meningococcal disease, sponsored by Novartis. Started Dec 2010; status: completed.
02
Drugs
Meningococcal ABCWY
03
Conditions
meningococcal meningitismeningococcal disease
Beyond the preview
Go deeper on NCT01210885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210885.